Evidence map›Paper›PMID 17614281›Full record

ArticleCurrent biology : CB2007

Differential susceptibility of yeast S and M phase CDK complexes to inhibitory tyrosine phosphorylation.

Mignon A Keaton, Elaine S G Bardes, Aron R Marquitz, Christopher D Freel, Trevin R Zyla, Johannes Rudolph, Daniel J Lew

Open access · bronzeAbstract read
In one paragraph

Article in Current biology : CB, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Multisite phosphorylation code of CDK.Nature structural & molecular biology · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A Wee1 checkpoint inhibits anaphase onset.The Journal of cell biology · 2013
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. The Renaissance or the cuckoo clock.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2011
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mignon A KeatonDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Elaine S G Bardes
Aron R Marquitz
Christopher D Freel
Trevin R Zyla
Johannes Rudolph
Daniel J Lew
Duke University Hospital · USDuke Medical Center · US

Funding

CELL CYCLE CHECKPOINT THAT MONITORS MORPHOGENESISR01GM053050 · NIGMS · DUKE UNIVERSITY · PI LEW, DANIEL J · 1995 to 2012
$4.0M
NIGMS NIH HHS GM 53050NIGMS NIH HHS R01 GM053050
6 · The paper itself

Abstract

backgroundSeveral checkpoint pathways employ Wee1-mediated inhibitory tyrosine phosphorylation of cyclin-dependent kinases (CDKs) to restrain cell-cycle progression. Whereas in vertebrates this strategy can delay both DNA replication and mitosis, in yeast cells only mitosis is delayed. This is particularly surprising because yeasts, unlike vertebrates, employ a single family of cyclins (B type) and the same CDK to promote both S phase and mitosis. The G2-specific arrest could be explained in two fundamentally different ways: tyrosine phosphorylation of cyclin/CDK complexes could leave sufficient residual activity to promote S phase, or S phase-promoting cyclin/CDK complexes could somehow be protected from checkpoint-induced tyrosine phosphorylation.

resultsWe demonstrate that in Saccharomyces cerevisiae, several cyclin/CDK complexes are protected from inhibitory tyrosine phosphorylation, allowing Clb5,6p to promote DNA replication and Clb3,4p to promote spindle assembly, even under checkpoint-inducing conditions that block nuclear division. In vivo, S phase-promoting Clb5p/Cdc28p complexes were phosphorylated more slowly and dephosphorylated more effectively than were mitosis-promoting Clb2p/Cdc28p complexes. Moreover, we show that the CDK inhibitor (CKI) Sic1p protects bound Clb5p/Cdc28p complexes from tyrosine phosphorylation, allowing the accumulation of unphosphorylated complexes that are unleashed when Sic1p is degraded to promote S phase. The vertebrate CKI p27(Kip1) similarly protects Cyclin A/Cdk2 complexes from Wee1, suggesting that the antagonism between CKIs and Wee1 is evolutionarily conserved.

conclusionsIn yeast cells, the combination of CKI binding and preferential phosphorylation/dephosphorylation of different B cyclin/CDK complexes renders S phase progression immune from checkpoints acting via CDK tyrosine phosphorylation.

Indexed as

ActinsBridged Bicyclo Compounds, HeterocyclicCDC28 Protein Kinase, S cerevisiaeCell Cycle ProteinsCyclin BCyclin-Dependent Kinase Inhibitor ProteinsDNA ReplicationMitosisMultiprotein ComplexesPhosphorylationProtein-Tyrosine KinasesProtein Tyrosine Phosphatasesras-GRF1Saccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsS PhaseActinsBridged Bicyclo Compounds, HeterocyclicCDC25 protein, S cerevisiaeCDC28 Protein Kinase, S cerevisiaeCell Cycle ProteinsCLB5 protein, S cerevisiaeCyclin BCyclin-Dependent Kinase Inhibitor Proteinslatrunculin AMultiprotein ComplexesProtein-Tyrosine KinasesProtein Tyrosine Phosphatasesras-GRF1Saccharomyces cerevisiae ProteinsSIC1 protein, S cerevisiaeSWE1 protein, S cerevisiaeThiazolidinesTyrosine

Identifiers

PMID17614281
PMCPMC2034293
OpenAlexW2042910530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.